BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 30791416)

  • 1. Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity.
    Thellung S; Corsaro A; Nizzari M; Barbieri F; Florio T
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death.
    Thellung S; Scoti B; Corsaro A; Villa V; Nizzari M; Gagliani MC; Porcile C; Russo C; Pagano A; Tacchetti C; Cortese K; Florio T
    Cell Death Dis; 2018 Feb; 9(2):166. PubMed ID: 29416016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynasore Suppresses mTORC1 Activity and Induces Autophagy to Regulate the Clearance of Protein Aggregates in Neurodegenerative Diseases.
    Chen Y; Xu S; Wang N; Ma Q; Peng P; Yu Y; Zhang L; Ying Z; Wang H
    Neurotox Res; 2019 Jul; 36(1):108-116. PubMed ID: 30924108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies for targeting neurodegenerative protein misfolding disorders.
    Scannevin RH
    Curr Opin Chem Biol; 2018 Jun; 44():66-74. PubMed ID: 29902695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin Protects Against Misfolded SOD1 Toxicity by Promoting Its Aggresome Formation and Autophagic Clearance.
    Yung C; Sha D; Li L; Chin LS
    Mol Neurobiol; 2016 Nov; 53(9):6270-6287. PubMed ID: 26563499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy and misfolded proteins in neurodegeneration.
    Metcalf DJ; García-Arencibia M; Hochfeld WE; Rubinsztein DC
    Exp Neurol; 2012 Nov; 238(1):22-8. PubMed ID: 21095248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Influence of Cyclo(His-Pro) on Proteostasis: Impact on Neurodegenerative Diseases.
    Grottelli S; Costanzi E; Peirce MJ; Minelli A; Cellini B; Bellezza I
    Curr Protein Pept Sci; 2018; 19(8):805-812. PubMed ID: 29708066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
    Maiti P; Manna J; Veleri S; Frautschy S
    Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats.
    Singh AK; Kashyap MP; Tripathi VK; Singh S; Garg G; Rizvi SI
    Mol Neurobiol; 2017 Oct; 54(8):5815-5828. PubMed ID: 27660271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers.
    Sarkar S
    Biochem Soc Trans; 2013 Oct; 41(5):1103-30. PubMed ID: 24059496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation.
    Martinez-Vicente M
    Semin Cell Dev Biol; 2015 Apr; 40():115-26. PubMed ID: 25843774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting autophagy in neurodegenerative diseases.
    Vidal RL; Matus S; Bargsted L; Hetz C
    Trends Pharmacol Sci; 2014 Nov; 35(11):583-91. PubMed ID: 25270767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Tools to Modulate Autophagy in Neurodegenerative Diseases.
    Suresh SN; Chakravorty A; Giridharan M; Garimella L; Manjithaya R
    J Mol Biol; 2020 Apr; 432(8):2822-2842. PubMed ID: 32105729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases.
    Hyttinen JM; Amadio M; Viiri J; Pascale A; Salminen A; Kaarniranta K
    Ageing Res Rev; 2014 Nov; 18():16-28. PubMed ID: 25062811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in autophagy-based neuroprotection.
    Radad K; Moldzio R; Al-Shraim M; Kranner B; Krewenka C; Rausch WD
    Expert Rev Neurother; 2015 Feb; 15(2):195-205. PubMed ID: 25614954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy Modulation as a Treatment of Amyloid Diseases.
    Mputhia Z; Hone E; Tripathi T; Sargeant T; Martins R; Bharadwaj P
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31527516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Clearance of Neurotoxic Misfolded Proteins by the Natural Compound Berberine and Its Derivatives.
    Rusmini P; Cristofani R; Tedesco B; Ferrari V; Messi E; Piccolella M; Casarotto E; Chierichetti M; Cicardi ME; Galbiati M; Geroni C; Lombardi P; Crippa V; Poletti A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.